SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial - Concepedia

Concepedia

Publication | Open Access

SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

DOI Full Paper Access

59

Citations

13

References

2022

Year

Kimberly A. Kraynyak, Elliott Blackwood, Joseph Agnes, Pablo Tebas, Mary Giffear, Dinah Amante, Emma L. Reuschel, Mansi Purwar, Aaron Christensen-Quick, Neiman Liu,

The Journal of Infectious Diseases

Abstract

NCT04336410.

References

	Year	Citations
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Alexandra C. Walls, Young‐Jun Park, M. Alejandra Tortorici, Cell Virus StructureSars-cov-2 Spike GlycoproteinViral PathogenesisGlycobiologyImmunology	2020	9K
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity Carolyn Rydyznski Moderbacher, Sydney I. Ramirez, Jennifer M. Dan, Cell	2020	1.9K
Immunogenicity of a DNA vaccine candidate for COVID-19 Trevor R.F. Smith, Ami Patel, Stephanie Ramos, Nature Communications	2020	635
Addressing the Cold Reality of mRNA Vaccine Stability Daan J.A. Crommelin, Thomas J. Anchordoquy, David B. Volkin, Journal of Pharmaceutical Sciences	2020	487
Safety and Immunogenicity of an Anti–Zika Virus DNA Vaccine New England Journal of Medicine	2017	309
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial Pablo Tebas, ShuPing Yang, Jean Boyer, EClinicalMedicine	2020	276
Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset Shirin Kalimuddin, C Tham, Martin Qui, Med	2021	199
From Vaccine Nationalism to Vaccine Equity — Finding a Path Forward Ingrid T. Katz, Rebecca Weintraub, Linda‐Gail Bekker, New England Journal of Medicine ImmunologyImmunodominanceVaccine EquityVaccine HesitancyUnited States	2021	176
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers Pablo Tebas, Kimberly A. Kraynyak, Ami Patel, The Journal of Infectious Diseases	2019	119
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes, npj Vaccines	2021	48

Page 1